Matthias Schwarz

Experience

• 

  Glaxo-Wellcome (Affymax)

  Jan 1995 - Jan 1998

  Research Scientist I/II, Supervisor Tech Staff

  Got acquainted with the latest technologies of Solid-phase Combinatorial Chemistry. Synthesized (and published on) various combinatorial libraries of several million compounds each.

• 

  Serono International S.A. (SPRI)

  Jan 1999 - Jan 2003

  Group Leader Medicinal Chemistry

  As one of the first three employees, helped build a functional, state-of-the-art Chemistry department from scratch.

• 

  Serono International S.A. (SPRI, then GRC)

  Jan 2003 - Apr 2007

  Director of Chemistry (Geneva)

  Continued building and expanding Chemistry department in Geneva. Acquired all necessary technologies to enable state-of-the-art Medicinal Chemistry work, comprising an Analytical Chemistry and a Bio-/Chemoinformatics group. Hired skilled personnel for the various areas moving to a final department size of 50 coworkers. Fostered a sense of family-like team spirit, motivation and scientific excellence amongst all department members.

• 

  Merck Serono International S.A.

  Jan 2007 - Jan 2011

  Global responsibility of Medicinal Chemistry, HT-Screening and Chemo-/Bioinformatics departments located in Boston, Darmstadt and Geneva (350 collaborators), plus of an external group of 100 persons working at Syngene (India). Primary objective : identify New Chemical Entities (NCEs) for Development. Secondary goals : contribute to elaborating a global research strategy prone to differentiate ourselves from the competitors. Ensure scientific consistency and cohesion between the various departments and sites. Foster team spirit and motivation across the three research sites. Show less

  • VP, Global Head of NCE Technologies

    Jan 2008 - Jan 2011

  • Global Director of Medicinal Chemistry

    Jan 2007 - Jan 2008
• 

  Merck Serono S.p.A.

  Jan 2012 - Jan 2015

  Senior Advisor in Business Development

  Evaluation of candidate molecules devleoped by other companies and/or of entire Biotech firms, for potential acquisition by Merck Serono. Internal formation in Business Administration

• 

  Schwarz Consulting & Translation

  Jan 2016 - now

  Independant Consultant and Translator

  https://www.schwarzcontra.com/

• 

  Drugs & Diagnostics for Tropical Diseases

  Nov 2020 - now

  Chief Scientist